Therapeutic Uses of Human Mesenchymal Stem Cells

Koc, Omer N.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project (R01)
• Project #: 5R01HL062360-02
• Application #: 6184625
• Study Section: Special Emphasis Panel (ZRG1-ET-1 (06))
• Program Officer: Wolpert, Mary K
• Project Start: 1999-04-19
• Project End: 2003-03-31
• Budget Start: 2000-04-01
• Budget End: 2001-03-31
• Support Year: 2
• Fiscal Year: 2000
• Total Cost: $189,786

Institution

• Name: Case Western Reserve University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 077758407
• City: Cleveland
• State: OH
• Country: United States
• Zip Code: 44106

Publications

Groh, Margaret E; Maitra, Basabi; Szekely, Emese et al. (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33:928-34

Maitra, B; Szekely, E; Gjini, K et al. (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33:597-604